The lncRNA SRA (steroid receptor RNA activator) was shown to promote hepatic steatosis via repression of adipose triglyceride lipase (Atgl) by inhibiting transcriptional activity of forkhead box protein O1 (FoxO1). This evidence concerns the gene PNPLA2 and Hepatic steatosis.